SUBSCRIBE
SUBSCRIBE
News   Policy

Insmed Incorporated to Discuss Litigation Settlement with Tercica, Inc.

March 7, 2007 | 
1 min read
RICHMOND, Va.--(BUSINESS WIRE)--Insmed (NASDAQ:INSM) announced that it will host a conference call on Wednesday, March 7 at 11:00 a.m. (ET) to discuss the litigation settlement with Genentech and Tercica, and other business details.
Events Legal
Insmed Incorporated
MORE ON THIS TOPIC
FDA Commissioner Dr. Marty Makary delivers remarks after President Donald Trump made an announcement on drug pricing, Tuesday, September 30, 2025, in the Oval Office. (Official White House Photo by Joyce N. Boghosian)
Government
Signs of Frustration Build Between Kennedy and FDA Commissioner Makary
November 17, 2025
 · 
2 min read
 · 
Tristan Manalac
factory of the pharmaceutical industry. pills on the conveyor
Manufacturing
Drugmakers Push FDA To Extend Support to Existing Facilities
November 11, 2025
 · 
4 min read
 · 
Nick Paul Taylor
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Cardiovascular disease
Amgen’s Repatha Cuts Risk of First Heart Attack by 36% in Phase III Trial
November 10, 2025
 · 
4 min read
 · 
Heather McKenzie
Vaccine concept. Conspiracy theory. Young woman against vaccination. Vector illustration in a flat style
Vaccines
Pesky ‘Macro Factors’—aka RFK Jr.—Come for Vaccine Pharmas’ Wallets
November 7, 2025
 · 
4 min read
 · 
Annalee Armstrong